| Vatalanib | IC50 | 140.0 [1] |
| 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide | IC50 | 170.0 [1] |
| N-(4-Chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 14100.0 [1] |
| Vandetanib | IC50 | 100.0 [1] |
| Staurosporine | IC50 | 5.4 [1], 8.19 [2], 15.97 [3], 19.0 [4], 35.0 [5] |
| 2-{[(Pyridin-4-yl)methyl]amino}-N-(quinolin-3-yl)benzamide | IC50 | 15.0 [1], 160.0 [2] |
| Semaxanib | IC50 | 8.0 [1], 43.0 [2], 3000.0 [3] |
| Linifanib | IC50 | 3.0 [1], 37.0 [2], 70.0 [3] |
| (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]pentanediamide | IC50 | 102700.0 [1], 160000.0 [2] |
| Sorafenib | IC50 | 18.0 [1], 31.0 [2], 165.0 [3] |
| Nintedanib | IC50 | 23.4 [1], 34.0 [2], 104.0 [3] |
| Foretinib | IC50 | 0.8 [1], 6.8 [2] |
| N4-(3-Bromophenyl)-6-(naphthalen-1-ylmethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 16000.0 [1], 19200.0 [2] |
| 4-N-(3-Bromophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1] |
| 4-N-(3-Bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 31100.0 [1], 45900.0 [2] |
| c[YYDEGLEE]-NH2 | IC50 | 23000.0 [1], 32000.0 [2], 39900.0 [3] |
| Sunitinib | IC50 | 1.0 [1] |
| Sunitinib | Ki | 2.0 [1] |
| Pazopanib | IC50 | 10.0 [1], 98.0 [2] |
| Dovitinib | IC50 | 3.0 [1], 10.0 [2] |
| Motesanib | IC50 | 2.0 [1] |
| Tivozanib | IC50 | 0.21 [1], 6.26 [2] |
| VEGF receptor tyrosine kinase inhibitor III | IC50 | 1.0 [1], 170.0 [2] |
| Lucitanib | IC50 | 7.0 [1] |
| N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[2-(triazol-1-yl)ethoxy]quinazolin-4-amine | IC50 | 700.0 [1] |
| Ilorasertib | IC50 | 1.25 [1], 32.0 [2] |
| Tak-593 | IC50 | 3.2 [1] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 7.76 [1], 8.51 [2] |
| 1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 2.0 [1] |
| 2-Benzyl-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 50000.0 [1] |
| 6-(2-Phenylethyl)-4-N-[3-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| 2-(2-Chlorobenzyl)-N4-(3-bromophenyl)-1H-indole-4,6-diamine | IC50 | 26800.0 [1] |
| N-(4-Chloro-2-fluorophenyl)-6-methoxy-7-(2-methoxyethoxy)quinazolin-4-amine | IC50 | 400.0 [1] |
| 4-N-(3-Bromo-4-fluorophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| 1-Methyl-1-[[5-[7-[(4-methylpiperazin-1-yl)methyl]-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]thiophen-2-yl]methyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 14.0 [1] |
| (4S)-5-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-Amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoic acid | IC50 | 28000.0 [1] |
| 4-N-[4-Fluoro-3-(trifluoromethyl)phenyl]-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| 4-N-(3-Bromophenyl)-6-[(2,4-dichlorophenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 50000.0 [1] |
| N4-(3-Bromophenyl)-2-(naphthalen-2-ylmethyl)-1H-indole-4,6-diamine | IC50 | 15200.0 [1] |
| N4-(3-Bromophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 45100.0 [1] |
| 4-N-(3-Ethynylphenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| 4-N-(4-Chloro-2-fluorophenyl)-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| N4-1H-Indol-5-yl-6-(2-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200000.0 [1] |
| Anilinoquinazoline deriv. 21 | IC50 | 1100.0 [1] |
| Anilinoquinazoline deriv. 22 | IC50 | 200.0 [1] |
| Anilinoquinazoline deriv. 28 | IC50 | 100.0 [1] |
| Anilinoquinazoline deriv. 32 | IC50 | 1500.0 [1], 15000.0 [2] |
| N-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-4-(thieno[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide | IC50 | 19.8 [1] |
| c[YYAEGLEE]-NH2 | IC50 | 25000.0 [1], 35000.0 [2] |
| 3-[(3S,6S,9S,12S,15S,18S,21S,26S)-26-Carbamoyl-12-(2-carboxyethyl)-15-(carboxymethyl)-18,21-bis[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-2,5,8,11,14,17,20,23-octaoxo-1,4,7,10,13,16,19,22-octazacyclohexacos-3-yl]propanoic acid | IC50 | 101000.0 [1], 105000.0 [2] |
| (3R,6S,9S,14S,17S,23S,26S)-9-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-3-(4-aminobutyl)-N-[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-17-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-23-(1H-imidazol-5-ylmethyl)-2,5,8,16,19,22,25-heptaoxo-1,4,7,15,18,21,24-heptazabicyclo[24.3.0]nonacosane-14-carboxamide | IC50 | 91600.0 [1], 105500.0 [2] |
| (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 36500.0 [1], 42300.0 [2] |
| (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 61200.0 [1], 61800.0 [2] |
| (2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamidopent-4-enoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxopent-4-en-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]pentanediamide | IC50 | 76800.0 [1], 98800.0 [2] |
| (2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]pent-4-enoyl]amino]-3-methylpentanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-1-oxopent-4-en-2-yl]pentanediamide | IC50 | 90300.0 [1], 109500.0 [2] |
| (3S,6S,9S,14S,17S,23S,26S,29S)-9-[[(2S)-2-Acetamido-4-methylsulfanylbutanoyl]amino]-3-(4-aminobutyl)-N-[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-17,23-bis(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-26-(1H-imidazol-5-ylmethyl)-2,5,8,12,16,19,22,25,28-nonaoxo-1,4,7,11,15,18,21,24,27-nonazabicyclo[27.3.0]dotriacontane-14-carboxamide | IC50 | 87600.0 [1], 93200.0 [2] |
| Methyl (2S,4R)-1-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]-4-hydroxypyrrolidine-2-carboxylate | IC50 | 10.0 [1], 15.0 [2] |
| N-[2-(Diethylamino)ethyl]-7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 5.0 [1], 13.0 [2] |
| N-[3-(Diethylamino)propyl]-7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 3.0 [1], 12.0 [2] |
| 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-(2H-tetrazol-5-yl)propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 4.0 [1], 20.0 [2] |
| 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[2-(2H-tetrazol-5-yl)ethyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 10.0 [1], 19.0 [2] |
| Ethyl 2-[4-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]piperazin-1-yl]acetate | IC50 | 5.0 [1], 13.0 [2] |
| 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-[3-(hydroxymethyl)piperidin-1-yl]propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 3.0 [1], 10.0 [2] |
| 7-[4-[(2-Fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-[2-(hydroxymethyl)morpholin-4-yl]propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 10.0 [1], 15.0 [2] |
| Methyl 2-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propylamino]acetate | IC50 | 6.0 [1], 11.0 [2] |
| Methyl 2-[3-[[7-[4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 9.0 [1], 14.0 [2] |
| Ethyl 4-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl]piperazine-1-carboxylate | IC50 | 13.0 [1], 14.0 [2] |
| Ethyl 4-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl]piperazine-1-carboxylate | IC50 | 9.0 [1], 14.0 [2] |
| Methyl 2-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propylamino]acetate | IC50 | 8.0 [1], 11.0 [2] |
| Methyl 2-[3-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]propyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 10.0 [1], 12.0 [2] |
| Methyl 2-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl-(2-methoxy-2-oxoethyl)amino]acetate | IC50 | 11.0 [1], 17.0 [2] |
| Methyl 1-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]pyrrolidine-3-carboxylate | IC50 | 8.0 [1], 17.0 [2] |
| Ethyl 2-[4-[2-[4-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]piperazin-1-yl]acetyl]piperazin-1-yl]acetate | IC50 | 10.0 [1], 13.0 [2] |
| Ethyl 2-[4-[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]piperazin-1-yl]acetate | IC50 | 17.0 [1], 112.0 [2] |
| Methyl 2-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethylamino]acetate | IC50 | 9.0 [1], 13.0 [2] |
| N-(2-Aminoethyl)-7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 11.0 [1], 15.0 [2] |
| Tert-butyl N-[2-[[7-[3-fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]thieno[3,2-b]pyridine-2-carbonyl]amino]ethyl]carbamate | IC50 | 60.0 [1], 69.0 [2] |
| 7-[3-Fluoro-4-[(2-fluoro-5-methylphenyl)carbamoylamino]phenoxy]-N-[3-(4-methylpiperazin-1-yl)propyl]thieno[3,2-b]pyridine-2-carboxamide | IC50 | 6.0 [1], 11.0 [2] |
| 2,3,7,8-Tetrachlorodibenzo-P-dioxin | Ki | 0.7 [1] |
| Erlotinib | IC50 | 1000.0 [1] |
| Hematoxyline | IC50 | 2900.0 [1] |
| Digitin | Ki | 1001.0 [1] |
| Crizotinib | IC50 | 1000.0 [1] |
| Dorsomorphin | IC50 | 11.0 [1] |
| Axitinib | IC50 | 0.1 [1] |
| Nintedanib esylate | IC50 | 34.0 [1] |
| Cediranib | IC50 | 5.0 [1] |
| Cabozantinib | IC50 | 12.0 [1] |
| Ponatinib | IC50 | 20.9 [1] |
| Chir-99021 | IC50 | 5000.0 [1] |
| Saracatinib | IC50 | 100000.0 [1] |
| Doramapimod | IC50 | 250.0 [1] |
| Quizartinib | IC50 | 10000.0 [1] |
| Orantinib | IC50 | 28.0 [1] |
| Brivanib | Ki | 60.0 [1] |
| 3,9-Bis((ethylthio)methyl)-K-252a | IC50 | 209.0 [1] |
| Nvp-tae 684 | IC50 | 872.0 [1] |
| (R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 59.0 [1] |
| Pyridone 6 | IC50 | 1520.0 [1] |
| 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 10.0 [1] |